Healthpeak Properties, Inc. $DOC Shares Sold by Catalyst Funds Management Pty Ltd

Catalyst Funds Management Pty Ltd trimmed its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 27.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 153,010 shares of the real estate investment trust’s stock after selling 56,802 shares during the period. Healthpeak Properties comprises 0.7% of Catalyst Funds Management Pty Ltd’s investment portfolio, making the stock its 23rd biggest holding. Catalyst Funds Management Pty Ltd’s holdings in Healthpeak Properties were worth $2,679,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in the stock. TCTC Holdings LLC raised its position in Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 751 shares during the period. Brooklyn Investment Group grew its stake in shares of Healthpeak Properties by 198.9% in the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 873 shares in the last quarter. Dagco Inc. purchased a new stake in shares of Healthpeak Properties in the 1st quarter valued at $30,000. AlphaQuest LLC acquired a new position in Healthpeak Properties during the 2nd quarter worth about $34,000. Finally, Atlantic Union Bankshares Corp purchased a new position in Healthpeak Properties during the 2nd quarter valued at about $34,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 0.3%

NYSE DOC opened at $17.64 on Thursday. Healthpeak Properties, Inc. has a 52 week low of $16.63 and a 52 week high of $22.71. The firm has a 50 day moving average of $18.31 and a two-hundred day moving average of $17.83. The company has a quick ratio of 1.28, a current ratio of 1.22 and a debt-to-equity ratio of 1.11. The stock has a market capitalization of $12.26 billion, a PE ratio of -352.63, a price-to-earnings-growth ratio of 3.84 and a beta of 1.10.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.01. The business had revenue of $705.87 million for the quarter, compared to analyst estimates of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The company’s revenue was up .8% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be given a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.9%. The ex-dividend date of this dividend is Friday, December 19th. Healthpeak Properties’s dividend payout ratio is currently -2,440.00%.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Morgan Stanley cut their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating on the stock in a research note on Friday, August 22nd. Weiss Ratings restated a “sell (d+)” rating on shares of Healthpeak Properties in a report on Tuesday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $18.00 target price (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 27th. Finally, Robert W. Baird cut their price objective on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $20.82.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.